| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA98755
Max Phase: Preclinical
Molecular Formula: C19H22BrNO4S
Molecular Weight: 440.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCS(=O)(=O)c1ccc(O)c(C(=O)Nc2ccc(Br)cc2)c1
Standard InChI: InChI=1S/C19H22BrNO4S/c1-2-3-4-5-12-26(24,25)16-10-11-18(22)17(13-16)19(23)21-15-8-6-14(20)7-9-15/h6-11,13,22H,2-5,12H2,1H3,(H,21,23)
Standard InChI Key: CQEAWKDWQAFRIR-UHFFFAOYSA-N
Associated Targets(non-human)
Actinomyces viscosus 309 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 440.36 | Molecular Weight (Monoisotopic): 439.0453 | AlogP: 4.76 | #Rotatable Bonds: 8 |
| Polar Surface Area: 83.47 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 6.05 | CX Basic pKa: | CX LogP: 4.74 | CX LogD: 3.45 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.58 | Np Likeness Score: -1.32 |
References
| 1. Clark MT, Coburn RA, Evans RT, Genco RJ.. (1986) 5-(Alkylsulfonyl)salicylanilides as potential dental antiplaque agents., 29 (1): [PMID:3941411] [10.1021/jm00151a004] |
Source
Source(1):